GB201416727D0 - Use - Google Patents

Use

Info

Publication number
GB201416727D0
GB201416727D0 GBGB1416727.4A GB201416727A GB201416727D0 GB 201416727 D0 GB201416727 D0 GB 201416727D0 GB 201416727 A GB201416727 A GB 201416727A GB 201416727 D0 GB201416727 D0 GB 201416727D0
Authority
GB
United Kingdom
Prior art keywords
use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1416727.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NovaBiotics Ltd
Original Assignee
NovaBiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NovaBiotics Ltd filed Critical NovaBiotics Ltd
Priority to GBGB1416727.4A priority Critical patent/GB201416727D0/en
Publication of GB201416727D0 publication Critical patent/GB201416727D0/en
Priority claimed from IL251040A external-priority patent/IL251040D0/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/145Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
GBGB1416727.4A 2014-09-22 2014-09-22 Use Ceased GB201416727D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1416727.4A GB201416727D0 (en) 2014-09-22 2014-09-22 Use

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
GBGB1416727.4A GB201416727D0 (en) 2014-09-22 2014-09-22 Use
SG11201701648UA SG11201701648UA (en) 2014-09-22 2015-09-21 Use of cysteamine in treating infections caused by yeasts/moulds
EP15770619.3A EP3197476A1 (en) 2014-09-22 2015-09-21 Use of cysteamine in treating infections caused by yeasts/moulds
KR1020177008807A KR20170052613A (en) 2014-09-22 2015-09-21 Use of cysteamine in treating infections caused by yeasts/moulds
PCT/GB2015/052714 WO2016046524A1 (en) 2014-09-22 2015-09-21 Use of cysteamine in treating infections caused by yeasts/moulds
BR112017005272A BR112017005272A2 (en) 2014-09-22 2015-09-21 cysteamine to treat yeast / mold infections
NZ730092A NZ730092A (en) 2014-09-22 2015-09-21 Use of cysteamine in treating infections caused by yeasts/moulds
AU2015323566A AU2015323566B2 (en) 2014-09-22 2015-09-21 Use of cysteamine in treating infections caused by yeasts/moulds
MX2017003550A MX2017003550A (en) 2014-09-22 2015-09-21 Use of cysteamine in treating infections caused by yeasts/moulds.
RU2017108196A RU2017108196A3 (en) 2014-09-22 2015-09-21
CA2959003A CA2959003A1 (en) 2014-09-22 2015-09-21 Use of cysteamine in treating infections caused by yeasts/moulds
JP2017515704A JP2017532317A (en) 2014-09-22 2015-09-21 Use of cysteamine in treating infections caused by yeast / filamentous fungi
CN201580051064.7A CN106687140A (en) 2014-09-22 2015-09-21 Use of cysteamine in treating infections caused by yeasts/moulds
ZA2017/01330A ZA201701330B (en) 2014-09-22 2017-02-22 Use of cysteamine in treating infections caused by yeasts / moulds
IL251040A IL251040D0 (en) 2014-09-22 2017-03-08 Use of cysteamine in treating infections caused by yeasts/moulds

Publications (1)

Publication Number Publication Date
GB201416727D0 true GB201416727D0 (en) 2014-11-05

Family

ID=51869299

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1416727.4A Ceased GB201416727D0 (en) 2014-09-22 2014-09-22 Use

Country Status (14)

Country Link
EP (1) EP3197476A1 (en)
JP (1) JP2017532317A (en)
KR (1) KR20170052613A (en)
CN (1) CN106687140A (en)
AU (1) AU2015323566B2 (en)
BR (1) BR112017005272A2 (en)
CA (1) CA2959003A1 (en)
GB (1) GB201416727D0 (en)
MX (1) MX2017003550A (en)
NZ (1) NZ730092A (en)
RU (1) RU2017108196A3 (en)
SG (1) SG11201701648UA (en)
WO (1) WO2016046524A1 (en)
ZA (1) ZA201701330B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201713324A (en) * 2015-07-02 2017-04-16 雷普特製藥有限公司 ADO-resistant cysteamine analogs and uses thereof
WO2018224813A1 (en) * 2017-06-06 2018-12-13 Novabiotics Limited Use of cysteamine compositions
WO2020079186A1 (en) * 2018-10-17 2020-04-23 Novabiotics Limited Dosage regime

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
US6086921A (en) * 1995-04-25 2000-07-11 Wintrop-University Hospital Metal/thiol biocides
EP3147293A1 (en) * 2004-08-18 2017-03-29 Novabiotics Limited Antimicrobial peptides
JP2006347990A (en) * 2005-06-20 2006-12-28 Pola Chem Ind Inc Antifungal medicine composition for nail
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
GB201021186D0 (en) * 2010-12-14 2011-01-26 Novabiotics Ltd Composition

Also Published As

Publication number Publication date
CA2959003A1 (en) 2016-03-31
MX2017003550A (en) 2017-07-28
RU2017108196A3 (en) 2019-06-19
AU2015323566B2 (en) 2018-03-22
WO2016046524A1 (en) 2016-03-31
RU2017108196A (en) 2018-10-24
AU2015323566A1 (en) 2017-04-06
SG11201701648UA (en) 2017-04-27
NZ730092A (en) 2018-05-25
CN106687140A (en) 2017-05-17
JP2017532317A (en) 2017-11-02
KR20170052613A (en) 2017-05-12
ZA201701330B (en) 2018-04-25
BR112017005272A2 (en) 2017-12-12
EP3197476A1 (en) 2017-08-02

Similar Documents

Publication Publication Date Title
HK1217861A1 (en) Wifi-coordinated laa-lte
GB201413019D0 (en) Beyond 1B
GB201419865D0 (en) Solution
IL251813D0 (en) Combination
GB201410907D0 (en) No details
GB201502152D0 (en) Novel use
HRP20181797T1 (en) Aminopyridyloxypyrazole compounds
SG11201605342UA (en) Compounds
ZA201607951B (en) Diaminotriazine compounds
GB201402431D0 (en) Compounds
GB201419094D0 (en) Anti-TIM-3-antibodies
GB201418300D0 (en) Compounds
GB201516146D0 (en) None
AU359704S (en) Case
GB201404893D0 (en) Selfie - Stick
AU361515S (en) Dishrack
GB2528557B (en) Soundbar
GB201415573D0 (en) Compounds
GB201410430D0 (en) Compounds
HUE044950T2 (en) Schienenmesssystem
GB201413050D0 (en) None
GB201418217D0 (en) No details
IL247073D0 (en) Combination
GB2529896B (en) Multirotor
GB201417561D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)